UM
IDXX icon

UniSuper Management’s Idexx Laboratories IDXX Stock Holding History

UniSuper Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.43M Buy
16,018
+6,827
+74% +$3.83M 0.04% 217
2026
Q1 		$5.16M Buy
9,191
+1,972
+27% +$1.26M 0.03% 257
2025
Q4 		$4.88M Sell
7,219
-1,345
-16% -$916K 0.03% 260
2025
Q3 		$5.47M Buy
8,564
+1,624
+23% +$986K 0.03% 256
2025
Q2 		$3.72M Sell
6,940
-810
-10% -$387K 0.02% 304
2025
Q1 		$3.25M Buy
7,750
+251
+3% +$109K 0.02% 325
2024
Q4 		$3.1M Sell
7,499
-10,080
-57% -$4.42M 0.02% 332
2024
Q3 		$8.88M Buy
17,579
+438
+3% +$213K 0.07% 170
2024
Q2 		$8.35M Buy
17,141
+2,340
+16% +$1.17M 0.07% 157
2024
Q1 		$7.99M Buy
14,801
+2,045
+16% +$1.12M 0.08% 149
2023
Q4 		$7.08M Sell
12,756
-524
-4% -$246K 0.08% 160
2023
Q3 		$5.81M Sell
13,280
-140
-1% -$69.8K 0.07% 165
2023
Q2 		$6.74M Buy
+13,420
New +$6.43M 0.08% 158

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

UniSuper Management's IDXX Position: Q2 2026 in Review

UniSuper Management increased its Idexx Laboratories (IDXX) stake by 74% in Q2 2026, buying an estimated $3.83M and bringing the position to 16,018 shares worth $8.43M. The position accounts for 0.04% of the portfolio, ranked #217.

UniSuper Management first reported a position in IDXX in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.88M in Q3 2024. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • UniSuper Management held 16,018 shares of Idexx Laboratories worth $8.43M as of Q2 2026.
  • UniSuper Management bought 6,827 Idexx Laboratories shares in Q2 2026, an estimated $3.83M.
  • Idexx Laboratories made up 0.04% of UniSuper Management's portfolio in Q2 2026, its #217 holding.
  • UniSuper Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Idexx Laboratories position peaked at $8.88M in Q3 2024.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.